These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18336948)

  • 1. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
    Silveira MG; Lindor KD
    J Hepatol; 2008 May; 48(5):692-4. PubMed ID: 18336948
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?
    Chapman RW
    Hepatology; 2009 Sep; 50(3):671-3. PubMed ID: 19714717
    [No Abstract]   [Full Text] [Related]  

  • 3. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A
    Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The medical management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.
    Cullen SN; Rust C; Fleming K; Edwards C; Beuers U; Chapman RW
    J Hepatol; 2008 May; 48(5):792-800. PubMed ID: 18314215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of primary sclerosing cholangitis with ursodeoxycholic acid].
    Stiehl A; Raedsch R
    Z Gastroenterol Verh; 1989 Jul; 24():136. PubMed ID: 2474928
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis.
    Rost D; Rudolph G; Kloeters-Plachky P; Stiehl A
    Hepatology; 2004 Sep; 40(3):693-8. PubMed ID: 15349909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward better treatment of primary sclerosing cholangitis.
    Kaplan MM
    N Engl J Med; 1997 Mar; 336(10):719-21. PubMed ID: 9041105
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
    Harnois DM; Angulo P; Jorgensen RA; Larusso NF; Lindor KD
    Am J Gastroenterol; 2001 May; 96(5):1558-62. PubMed ID: 11374699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and medical therapy of primary sclerosing cholangitis.
    van Milligen de Wit AW
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):940. PubMed ID: 10514135
    [No Abstract]   [Full Text] [Related]  

  • 11. Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy.
    Fong DG; Lindor KD
    Am J Gastroenterol; 2000 Aug; 95(8):1861-2. PubMed ID: 10950026
    [No Abstract]   [Full Text] [Related]  

  • 12. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid.
    Rudolph G; Kloeters-Plachky P; Rost D; Stiehl A
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):487-91. PubMed ID: 17489059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the cholehepatic shunt as a potential therapy for primary sclerosing cholangitis.
    Glaser SS; Alpini G
    Hepatology; 2009 Jun; 49(6):1795-7. PubMed ID: 19475683
    [No Abstract]   [Full Text] [Related]  

  • 14. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
    Fickert P; Wagner M; Marschall HU; Fuchsbichler A; Zollner G; Tsybrovskyy O; Zatloukal K; Liu J; Waalkes MP; Cover C; Denk H; Hofmann AF; Jaeschke H; Trauner M
    Gastroenterology; 2006 Feb; 130(2):465-81. PubMed ID: 16472600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
    Suskind DL; Finn L; Wahbeh G; Christie D; Horslen S
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):542-4. PubMed ID: 17033534
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
    MMW Fortschr Med; 2006 Jun; 148(24):42-3. PubMed ID: 16850808
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary sclerosing cholangitis. Ursodeoxycholic acid is without clinical effect].
    Eisenburg J
    Fortschr Med; 1997 Jun; 115(18):7-8. PubMed ID: 9324488
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical approaches to primary sclerosing cholangitis.
    Kaplan MM
    Semin Liver Dis; 1991 Feb; 11(1):56-63. PubMed ID: 2047891
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possible treatment modalities of primary sclerosing cholangitis].
    Lengyel G; Tulassay Z
    Orv Hetil; 2005 Dec; 146(49):2479-83. PubMed ID: 16398312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment for primary sclerosing cholangitis: risk versus benefit.
    Angulo P; Lindor KD
    Hepatology; 2000 Oct; 32(4 Pt 1):871-2. PubMed ID: 11003638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.